Also trades as: 3839.HK (HKSE) · $vol 0M
CAIHF OTC
CPBIO Holding Company Limited
1W: +0.0%
1M: +0.0%
3M: +282.1%
YTD: +282.1%
1Y: +282.1%
$1.07
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$537M
+73.7% ▲
5Y CAGR: +41.8%
Gross Profit
$78M
+57.8% ▲
5Y CAGR: +25.5%
Operating Income
$39M
+247.1% ▲
5Y CAGR: +97.6%
Net Income
$32M
+186.3% ▲
5Y CAGR: +14.6%
EPS (Diluted)
$0.13
+193.5% ▲
5Y CAGR: +15.2%
EBITDA
$48M
+104.3% ▲
5Y CAGR: +52.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $142M | $160M | $174M | $309M | $537M |
| YoY Growth | +51.6% | +12.5% | +9.0% | +77.6% | +73.7% |
| Cost of Revenue | $107M | $120M | $144M | $260M | $459M |
| Gross Profit | $35M | $39M | $30M | $49M | $78M |
| Gross Margin | 24.4% | 24.6% | 17.3% | 15.9% | 14.4% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $30M | $34M | $35M | $38M | $39M |
| Operating Expenses | $30M | $34M | $35M | $38M | $39M |
| Operating Income | $5M | $5M | -$5M | $11M | $39M |
| Operating Margin | 3.5% | 3.1% | -2.6% | 3.6% | 7.3% |
| Interest Expense | $648K | $994K | $2M | $2M | $2M |
| Income Before Tax | $31M | -$3M | $3M | $16M | $44M |
| Tax Expense | $5M | $2M | $1M | $2M | $7M |
| Net Income | $19M | -$7M | $3M | $11M | $32M |
| Net Margin | 13.7% | -4.2% | 1.5% | 3.6% | 6.0% |
| EPS (Diluted) | $0.08 | $-0.03 | $0.01 | $0.04 | $0.13 |
| EBITDA | $12M | $12M | $11M | $24M | $48M |
| Shares Outstanding | 253M | 253M | 253M | 253M | 253M |